Aspirin

Product NDC: 17856-3086
11-digit product format: 178563086
Labeler code: 17856
Product ID: 17856-3086_385229c2-9b6a-56ca-e063-6394a90aa5b7
Type: HUMAN OTC DRUG
Nonproprietary name: Aspirin
Dosage form: TABLET, DELAYED RELEASE
Route: ORAL
Labeler: ATLANTIC BIOLOGICALS CORP.
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2019-07-01
Substance: ASPIRIN
Active strength: 81 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 26 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17856-3086-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17856-3086-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17856-3086-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17856-3086-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17856-3086-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17856-3086-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17856-3086-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17856-3086-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17856-3086-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17856-3086-1	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	17856-3086-1	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17856-3086-1	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17856-3086-1	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Aspirin
Brand name suffix: Low Dose
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	81 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308416	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
024c5054-959f-4ea5-a71f-c0e16cc4b90c	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fb7ab793-2c12-4079-b100-a64f73bef25a	Product name	4	20240712
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
b0cbf770-6cc3-4aa4-9158-755110c2b9f7	Product name	2	20230717
dc7c5daa-021f-40dd-b00d-63982cb2067a	Product name	1	20230426
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
3c386306-c48a-413e-bb69-70cb268496f3	Product name	1	20210727
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	5	20200925
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
08ffbcbf-26df-b99c-1dab-64fc4cfae89f	Product name	2	20160823
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
17856-3086-1	2025-04-18	C162847	48780-1	f386c64a-26ff-0266-e053-dadaa90a7c1a	Aspirin 81mg Low-dose
17856-3086-1	2023-01-30	C162847	48780-1	f386c64a-26ff-0266-e053-dadaa90a7c1a	Aspirin 81mg Low-dose

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17856-3086-1	AspirinLow Dose	1 in 1 BOX, UNIT-DOSE	TABLET, DELAYED RELEASE	1		3
17856-3086-1	AspirinLow Dose	1 in 1 POUCH	TABLET, DELAYED RELEASE	1		3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17856-3086-1	EA - Each	17856-3086	4226316e-1064-4099-b6f4-af63f773d033	1	2022-05-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17856-3086	ASPIRIN LOW DOSE (ASPIRIN) TABLET, DELAYED RELEASE [ATLANTIC BIOLOGICALS CORP.]	2	Current NDC, Legacy NDC, 2 package rows	20250418_024c5054-959f-4ea5-a71f-c0e16cc4b90c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 10 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Headache Relief Extra Strength	ACETAMINOPHEN, ASPIRIN, CAFFEINE	P & L Development, LLC	55e996cd-ef22-4e09-a05c-8aa994e4540b	2026-06-12	Warnings	Exact identifier application number: M013
CHILDRENS TYLENOL	ACETAMINOPHEN	Kenvue Brands LLC	3162733b-9382-39f1-e063-6294a90ac420	2026-06-12	Warnings	Exact identifier application number: M013
Acetaminophen Extra Strength	ACETAMINOPHEN	Dr. Reddy's Laboratories Inc.	9769e0c0-2f4c-3b7a-1a65-c98fbce11681	2026-06-12	Warnings	Exact identifier application number: M013
ACETAMINOPHEN	ACETAMINOPHEN	NuCare Pharmaceuticals, Inc.	54010ddf-25d1-2016-e063-6294a90a877d	2026-06-11	Warnings	Exact identifier application number: M013
ACETAMINOPHEN	ACETAMINOPHEN	Preferred Pharmaceuticals Inc.	983debdf-4a61-4dde-ba34-567fdd17720e	2026-06-11	Warnings	Exact identifier application number: M013
Acetaminophen Liquid / Acetaminophen Diphenhydramine HCl Liquid	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	WALGREENS	40b4fe91-b1dd-147c-e063-6294a90a807d	2026-06-09	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	PUBLIX SUPERMARKETS, INC	3f17fa06-4932-b8ec-e063-6294a90a0381	2026-06-09	Warnings	Exact identifier application number: M013
Sleep Aid Plus Pain Relief	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	Walgreen Company	e3929179-dad2-4f7e-a971-dbf80f2b5e1b	2026-06-08	Warnings	Exact identifier application number: M013
LOW DOSE ASPIRIN	ASPIRIN	Pinnacle RX LLC	53c11fb4-ba31-b5e5-e063-6394a90a9c1a	2026-06-08	Warnings	Exact identifier application number: M013
Pain Reliever PM	ACETAMINOPHEN, DIPHENHYDRAMINE HCL	Walgreen Company	9655c38a-126b-459e-b31d-0aa33d9eb522	2026-06-08	Warnings	Exact identifier application number: M013
Acetaminophen Regular Strength	ACETAMINOPHEN	Aurohealth LLC	dce938f5-eeba-4a76-9261-2b1324c39a31	2026-06-08	Warnings	Exact identifier application number: M013
Childrens Mapap	ACETAMINOPHEN	Bryant Ranch Prepack	69c90cc8-846a-42cf-933a-108671689e8f	2026-06-05	Warnings	Exact identifier application number: M013
Aspirin Low Dose	ASPIRIN	Rugby Laboratories	63fcd93a-b1db-44ba-8f2b-055a7deb205d	2026-06-04	Warnings	Exact identifier application number: M013
Acetaminophen	ACETAMINOPHEN	ASCLEMED USA INC.	707a9ea7-8f4e-4274-97bd-b8071a0ee06b	2026-06-04	Warnings	Exact identifier application number: M013
Aspirin Adult low dose	ACETYLSALICYCLIC ACID	Medline Industries, LP	6dd6501f-841c-4994-e053-2a91aa0ae231	2026-06-04	Warnings	Exact identifier application number: M013
Medline	ACETAMINOPHEN	Medline Industries, LP	fc5e6f2a-e813-0666-e053-6394a90a66a7	2026-06-04	Warnings	Exact identifier application number: M013
Medline	ACETAMINOPHEN	Medline Industries, LP	fc5d92c2-4bbe-8ad1-e053-6294a90a65b6	2026-06-04	Warnings	Exact identifier application number: M013
acetaminophen	ACETAMINOPHEN	Unit Dose Solutions, Inc.	537219ac-552a-a30e-e063-6394a90aa9d1	2026-06-04	Warnings	Exact identifier application number: M013
Pain Relief childrens	ACETAMINOPHEN	CVS PHARMACY	ff878f56-125a-4de7-b063-029f7030733d	2026-06-04	Warnings	Exact identifier application number: M013
Back and Body Extra Strength	ASPIRIN, CAFFEINE	CVS Pharmacy	749e2be2-594a-4052-8fa5-45c9ade2d23c	2026-06-03	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	024c5054-959f-4ea5-a71f-c0e16cc4b90c	3
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	024c5054-959f-4ea5-a71f-c0e16cc4b90c	3
308416	ASA 81 MG Delayed Release Oral Tablet	SY	024c5054-959f-4ea5-a71f-c0e16cc4b90c	3
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	024c5054-959f-4ea5-a71f-c0e16cc4b90c	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
17856-3086-1	17856308601	1 POUCH in 1 BOX, UNIT-DOSE (17856-3086-1) / 1 TABLET, DELAYED RELEASE in 1 POUCH	1 pouch	2021-04-23	0000-00-00	No	No	Current